View Article

Abstract

Oral route drug delivery system is still considered as the most convenient and patient friendly drug delivery route. Odf’s are an innovative dosage form that breaks down and dissolves within the oral cavity. Notably, fast-dissolving oral thin films offer a practical solution for a patients such as those in pediatric, as well as geriatric population who struggle with a tablet or hard gelatin capsule ingestion. These rapid- dissolving films are better than fast-disintegrating tablets since the latter have choking and friability issues. This drug delivery technology offers several benefits over traditional fast-disintegrating tablets, including the ability to be used for dysphasic and schizophrenic patients and the capacity to be taken without water due to their quick disintegration and rapid release of medicine in the mouth. This present review provides a brief summary of challenges, composition, formulation methods and evaluation parameters employed for oral disintegrating.

Keywords

Oral disintegrating films, Challenges, Composition and formulation of drug, evaluation parameters.

Introduction

“These are drug delivery systems that they are quickly releasing the drug by dissolving or adhering in the mucosa with saliva within a few seconds due to it contains water-soluble polymers when it placed in the mouth cavity or on the tongue”. The oral route is the most preferred route by patients among the several routes of administration. Most pharmaceutical firms have focused their research efforts on finding feasible oral dosage form options for pediatric, geriatric, noncompliant, or nauseated patients [2]. There are 3 different subtypes of oral film, which are classified according to several factors including surface area, thickness, structure, excipients, and application area. These drug delivery systems can be applied topically, buccally, sublingually, orally, or by a combination of these routes. When placed on the tongue, these films exhibit the behaviour of either dissolving or disintegrating in salivary fluids without the need for water, making them an alternative to rapidly dissolving tablets. The improved systemic bioavailability is owing to the bypassing of the first pass effect and improved permeability as a result of well-supplied vascular and lymphatic drainage [6].

ADVANTAGES

1. Reducing the chance of choking 

  1. By avoiding first-pass metabolism, lesser dosages can produce a quicker onset of effect. 
  2. Good flavour 
  3. Exceptional stability 
  4. Convenient for persons with dysphasia who have trouble swallowing tablets and      capsules[1].
  5. Avoiding the hepatic first pass effect results in increased bioavailability, stability, and a quick beginning of action.
  6. Simple equipment and affordable, non-sophisticated methods can be used to generate these videos [2].

 DISADVANTAGES

  1. Failure to oblige drugs with tall dosage.
  2. Rapid discharge
  3. Mucoadhesive release [1].
  4. High measurements cannot be acclimatized.
  5. It is not doable to utilize drugs having unpleasant taste.
  6. Maintaining measurements consistency is difficult.
  7. This method of delivery cannot be used for medications that irritate oral mucosa[2].

Oral Mucosa

Three layers of cells make up the verbal mucosa :

  • Stratified epithelium : The cellar film isolates this peripheral layer in the verbal depth from the connective tissue.
  • Lamina propria : Situated underneath the cellar film, this layer comprises of connective tissue (3)
  • Submucous layer : Acting as the verbal cavity’s least layer.

       
            Structure of oral mucosa.png
       

Figure No. 1 :- Structure of oral mucosa (Mahajan et al., 2013)

Concentration Of Components 


Table No. 1 :- Concentration of components    

 

Sr. No.

Ingredients

Concentration

1.

Drug

1-30%

2.

Film-forming polymer

40-50%

3.

Plasticizer

0-20%

4.

Saliva stimulating agent

2-6%

5.

Sweetening agent

3-6%

6.

Flavouring agent

Q. S

7.

Surfactant

Q. S

8.

Colours, Filler

Q. S


Composition Of Oral Disintegrating Films

Drug

Typically constituting 1-30% w/w in a standard film, the medicate is significant for dynamic definition. The consolidation of micronized API is basic to upgrade the film’s surface and guarantee fast disintegration and consistent in the fast-disintegrating film. [5]. API to be joined into ODF in a perfect world ought to be low dosage, non-bitter and have highwater solubility (BSC class 1 such as paracetamol, propranolol and diltiazem).[6] Drugs counting salbutamol sulphate, rizatriptan benzoate, verapamil, ondansetron, dexamethasone, rofecoxib, cetirizine, pilocarpine, tianeptine sodium, indomethacin, etc. are as often as possible included in ODFs. Furthermore, an ODF containing a prochlorperazine an anti-emetic sedate was created utilizing microcrystalline cellulose and other film-forming polymer.[2]  

Hydrophilic Polymers

Hydrophilic polymer is the fundamental operator in shaping the film. Hydrophilic polymer can break up in water effortlessly. The lower the atomic weight of the polymer, the quicker the disintegration rate [6].

Ideal properties of polymer -

  1. Polymer must have great spreadability.
  2. Non aggravation.
  3. Non poisonous.
  4. Ought to have great mechanical strength.
  5. Polymer ought to have suitable rack life.

Plasticizers

In common, including plasticizer to details moves forward mechanical properties counting pliable quality and percent stretching [2]. The cautious choice of appropriate plasticizers is basic to guarantee compatibility with the medicate, polymers, and other excipients, anticipating part, splitting, and peeling issues. [7]. A few of the most commonly utilized plasticizer incorporate glycerol, propylene glycol, PEG, dimethyl, castor oil, etc[2].

Sweetning Agent

To cover up the foul taste and smell of the active substance, a sweetening agent is required. There are two categories of sweetening agents: artificial and natural sources[6]. All natural sweeteners belong to the saccharide family; examples of natural sugars include sucrose, dextrose, fructose, glucose, liquid glucose, and isomaltose. Artificial sweeteners include cyclamate, aspartame, acesulfame K, sucralose, alitame, neotame, and saccharin.[2]

Saliva Stimulating Agent

Saliva incitement chemicals are utilized to boost spit generation, which makes a difference the details for quick crumbling strip items break down more rapidly. The substances that are most as often as possible used incorporate citric corrosive, lactic corrosive, maleic corrosive, ascorbic corrosive, tartaric corrosive etc[2] Examples of spit invigorating specialists are citric corrosive or ascorbic corrosive at 26% w/w utilized alone or in combination [6].

Flavouring Agent

Flavors play a significant role in masking the bitter and unpleasant taste of the API. Apart from taste and personal liking, the age of the target user can influence selection of flavors. Younger people prefer fruit punch, raspberry etc. whereas geriatric prefers orange, lemon and mint [6].

Electronic tongues are used to assess the effectiveness of various taste masking agents. According to a study, the bitter taste of diclofenac sodium may be effectively covered up by a blend of the flavours by mint, liquorice, and sucralose [2].

Surfactant

Surfactant is utilized to improve the solvency and wetting property of the film, permitting it to be discharged inside minutes or less than that [6]. Poloxamer 407, benzathanium chloride, sodium lauryl sulphate, tweens, benzalkonium chloride, and other common fixings are utilized. The most regularly utilized surfactant among them is poloxamer 40 [2].

Colouring Agent

As colouring agents, pigments are employed. ODFs and other medicinal preparations most frequently utilise titanium dioxide as a colorant. In addition to titanium dioxide, a broad spectrum of colours, such as FD and C, natural hues, and customised pantone matched hues, are offered [2].

Method Of Preparation

There are numerous strategies utilized to define ODF such as dissolvable casting strategy, semisolid casting, rolling strategy, strong scattering expulsion and splashing strategy. Diverse strategy has distinctive points of interest and drawbacks that can be considered some time recently doing the film [6]. We are study various types of methods such are following

  1. Solvent Casting Method

Solvent casting strategy the least difficult however the most seasoned film-making strategy. The API is broken down in a reasonable dissolvable. Polymers, plasticizers and any other fixings can be broken in another parcel of dissolvable to plan a polymeric solution [6].

       
            Solvent casting method.jpg
       

Figure No. 2 :- Solvent casting method (Ghodake et al., 2013)

ODF’S By Using Solvent Casting Method by An Some API 

1. Captopril

Preparation Of ODF’S

ODFs were arranged utilizing full factorial DoE approach utilizing two components and three levels (32) utilizing the statistica form 13.1 computer program (TIBCO Statistica Inc., CA, USA), coming about in nine definitions. The movies were arranged by dissolvable casting strategy utilizing HPMC E6 (2%, 2.5%, and 3%) as a film- forming operator, and GLY, PP or PEG as plasticizers (10% mass polymer, w/w). EDTA was utilized as an antioxidant specialist . To get ready the definitions 25 mg of CPT was weighed, scattered in adequate sum of filtered water, and subjected to blending on a 10position attractive stirrer. At that point, the plasticizer (GLY,PP, OR PEG) and HPMC E6 (2%, 2.5%, or 3%) were included, and the volume was completed with filtered water (q.s. to 6ml). After 30 min, blending was halted, and the scatterings were kept at rest for 30 min for deaeration. The scatterings in this way gotten were exchanged to a polystyrene shape (120 x120mm,144 cm2 of range), and dried in an stove with constrained discuss circulation and reestablishment (40.0  ± 0.5°C) for 24 h. The movies  were evacuated from the molds., wrapped in an aluminium thwart, and put in a desiccator. The sum of CPT in ODF’s was calculated concurring to Ali, such that each unit of ODF (6 cm2) contains 25 mg of CPT. Movies without plasticizer (F1-WP, F4-WP and F7-WP) were arranged for comparison [9].


Table No. 2 :-   Composition  Of  Captopril [9]

 

Composition

ODFs

F1

F2

F3

F4

F5

F6

F7

F8

F9

CPT (mg)

600

600

600

600

600

600

600

600

600

HPMC E6 LV (%)

2.0

2.0

2.0

2.5

2.5

2.5

3.0

3.0

3.0

EDTA Na (%)

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

1Plastificizer

GLY

PP

PEG

GLY

PP

PEG

GLY

PP

PEG

Water, q.s. (mL)

45

45

45

45

45

45

45

45

45


1equivalent to 10% of the polymer mass  

2. Aprepitant

Preparation of drug loaded fast dissolving films

Polymeric solution (Solution A) was prepared by dissolving desired amount of pullulan in sufficient quantity of distilled water (70%). Specific quantity of drug along with polyethylene glycol and other excipients were dissolved in remaining water (30%) with continuous stirring (Solution B). Solution B was slowly added in polymeric solution A with continuous stirring. Final solution obtained was kept aside for 30 mins for defoaming. After defoaming, solution was poured in petri plate and dried at 45 °C in hot air oven for 24 h . Film casted in petri plate was then carefully peeled off and cut into pieces of desired shape and size. Different optimized combinations of film containing pullulan with PEG 400 were prepared and evaluated for the disintegration time, wetting time, folding endurance and drug release[10].

Preparation of pullulan based fast dissolving film of aprepitant using experiment


Table No. 3: - Composition Of Aprepitant [10]

 

Ingredients

BF1

BF2

BF3

BF4

BF5

BF6

Pullulan (mg)

50

100

150

200

250

300

PEG 400 (mg)

16

32

48

64

80

96

Citric acid (mg)

15

15

15

15

15

15

Tween 80 (ml)

0.06

0.06

0.06

0.06

0.06

0.06

Mannitol (mg)

15

15

15

15

15

15

Water (ml)

20

20

20

20

20

20

Ingredients

BF1

BF2

BF3

BF4

BF5

BF6

Pullulan (mg)

50

100

150

200

250

300

PEG 400 (mg)

16

32

48

64

80

96


3. Zolmitriptan

Preparation of standard solution

10 mg of zolmitriptan was accurately weighed into 10 ml volumetric flask and dissolved in small quantity of  phosphate buffer pH 6.8 finally the volume was made up to 10 ml with pH 6.8 bufferi1 ml of the above solution was pipette into another 10 ml volumetric flask and the volume was made up to 10 ml pH 6.8 phosphate buffers (100 µg/ml). From the above stock-2 solution 0.2, 0.4, 0.6, 0.8 and 1ml solution was pipette out into 5 different 10ml volumetric flask respectively and the volume was made up to 10 ml with phosphate buffer pH 6.8 (2 µg/ml,4 µg/ml, 6 µg/ml, 8 µg/ml, 10 µg/ml) [1].

Preparation of fast disintegrating films

Solvent casting evaporation was used to create fast-dissolving films of zolmitriptan. The film was carefully extracted from its original shape and trimmed to a size of 10 x 10 cm?2;.Medifilms are stored in airtight containers and are subjected to evaluation studies. Design Expert portable software was used to carry out the statistical analysis of the experimental work. These factors were used in the design and formulation of films. To derive the second-order polynomial equation, an i3factor, i2-level full factor design methodology was employed. Concentration of HPMC iE i5i(X1), iPGi(X2), iSSGi(X3), and integration time (Y1), in vitro drug release (Y2), and endurance time (Y3) are examples of independent variables [1].


Table No. 4 :- Formulation Table Of Zolmitriptan [1]

 

 

S. no

 

Ingredients

 

 

Formulation codes

 

 

 

F1

 

F2

 

F3

 

F4

 

F5

 

F6

 

F7

 

F8

 

1

Zolmitriptan

(mg)

1

2

5

1

2

5

1

2

5

1

2

5

1

2

5

1

2

5

1

2

5

1

2

5

2

HPMC E

5 (%)

4

4

6

6

6

4

6

4

3

Propylene  glycol

(ml)

1

1

3

1

1

3

3

3

4

Sodium starch

2

4

2

2

4

4

4

2

 

glycolate (%)

 

 

 

 

 

 

 

 

5

Aspartate

(mg)

1

5

1

5

1

5

1

5

1

5

1

5

1

5

1

5

6

Water

(ml)

1

0

1

0

1

0

1

0

1

0

1

0

1

0

1

0


4. Ramosetron Hydrochloride 

 Preparation of film

 Mouth dissolving film of Ramosetron Hydrochloride was arranged by the dissolvable casting strategy. The watery arrangement was arranged by dissolving the water-soluble polymer in water. The other fixings were broken up in Ethanol 95% arrangement. Both mixtures were mixed to form homogenous viscous solution. The entrapped air was removed by putting it into sonicator. The coming about arrangement was casted as a film on a petridish and was permitted to dry. Arranged movies were carefully evacuated from the petridish, checked for any blemishes and at that point cut into the 2×2 cm2, each containing 5 mg Ramosetron Hydrochloride. The movies were put away in air proof plastic holder till assist use[12].


Table No. 5 :- Composition Of Aspartame Film[12]

      

Ingredient

F1

F2

F3

Ramosetron Hydrochloride (mg)

73.075

73.075

73.075

HPMC E5 (mg)

500

500

500

PEG 400 (%)

15

15

15

Aspartame (mg)

10

20

30

Menthol (mg)

40

40

40

Ethanol (ml)

7

7

7

Distilled Water (ml)

5

5

5


  1. Hot Melt Extrusion

Polymers with low atomic weight and moo consistency are utilized in hot soften expulsion. The HME prepare has been connected as often as possible in pharmaceutical industry. In spite of the fact that the handle is unacceptable for thermolabile API, the strategy offers bounty of points of interest such as diminished chance of discuss entanglement, great reasonableness for scale up, more uniform scattering of fine particles due to seriously blending and disturbance, as well as great control of working parameters. [6].

          
            Hot soften expulsion strategy.png
       

  
Figure No. 3 :- Hot soften expulsion strategy (Muhammed et al., 2023)

ODF’S By Using Hot Melt Extrusion By An Some API

1.Zolpidem Tartarate

1.1 Formulation Advancement

1.1.2. Placebo Formulations

Placebo definitions were arranged by utilizing dissolvable casting strategy. The film shaping polymers HPMCE5, GUAR GUM and SODIUM ALGINATE were precisely weighed and scattered in 10 ml of refined water each and at that point doused for 4 hours. To these polymer arrangements, Mannitol was included with nonstop mixing on a attractive stirrer. The coming about bubble free arrangement was poured on to a glass plate and was dried at 50oC in hot discuss broiler for 24 hr. The fake treatment movies shaped were carefully evacuated from glass plate and assessed for drying time, normal weight, thickness, ductile quality, collapsing continuance and in vitro deterioration time [14].

2.1 Drug Loaded Formulation

The composition for the sedate stacked movies is given. The method taken after was comparative to the fake treatment details. The Zolpidem Tartarate was included to the polymer arrangement and sonicated for 15 minutes till the sedate was totally broken up.  The medicate stacked movies were assessed for normal weight, thickness, malleable quality, collapsing perseverance, in vitro deterioration time and in vitro disintegration studies [14].

 


Table No. 6 :- Composition Of Zolpidem Tartarate Films[14]

 

 

HPMC E5

Guar Gum

Ingredients

F1

F2

F3

F4

F5

F6

F7

Drug (mg)

62.5

62.5

62.5

62.5

62.5

62.5

62.5

Polymer (mg)

125

187.5

250

62.5

125

187.5

250

Glycerol (mg)

18.7

28.1

37.5

9.38

18.7

28.1

37.5

Mannitol (mg)

100

100

100

100

100

100

100

Flavour

5%

5%

5%

5%

5%

5%

5%

Distilled

Water(ml)

10

10

10

10

10

10

10


  1. Solid Dispersion Method

This method employments undefined hydrophilic polymers to help the scattering of one or more drugs in a strong shape inside an dormant carrier to make a arrangement, and the medication is to begin with broken down in a appropriate dissolvable [16]. At that point, without expelling the fluid dissolvable, this arrangement is included to the liquefy of an fitting polymer, such as polyethylene glycol, that has come to a temperature beneath 70 oC. At long last,  the strong scatterings are shaped into movies utilizing kicks the bucket [17].

ODF’S By Using Solid Dispersion Method By An Some API

1.Telmisartan

Formulation of oral fast dissolving films

The fast-dissolving films were prepared by solvent casting technique. Hypromellose was used as a film-forming hydrocolloid. Accurately weighed quantity of hydrocolloid was dissolved in a specified quantity of water. A weighted quantity of propylene glycol as a plasticizer was added to the above solution and dissolved by using a magnetic stirrer. Weighed quantity of Telmisartan SD was dissolved in 2 ml of appropriate solvent, separately. Solution of Telmisartan Solid Dispersion was added to a previously prepared solution of hydrocolloid and plasticizer and mixed thoroughly. The above solution is kept aside for 10 minutes for removal of air bubbles or may keep for sonication if required. Then cast on Petri plate and dried overnight to form the film. Then the film was carefully removed and cut into suitable size i.e. 2cm x 2cm. The above solution is kept aside for 10 minutes for removal of air bubbles or may keep for sonication if required. Then cast on Petri plate and dried overnight to form the film. Then the film was carefully removed and cut into suitable size i.e. 2cm[18].


Table No. 7:- Formulation Table Of Telmisartan[18]

 

Formulation Ingredients

Formulation Code

F1

F2

F3

F4

F5

F6

F7

F8

F9

Telmisartan (mg)

664

 

664

664

664

664

664

664

664

664

HPMC (mg)

600

 

650

700

600

650

700

600

650

700

SSG (mg)

8

 

8

8

12

12

12

16

16

16

PG (ml)

0.6

 

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

Citric Acid (mg)

10

 

10

10

10

10

10

10

10

10

Mannitol

(mg)

20

 

20

20

20

20

20

20

20

20

Water upto

30

 

30

30

30

30

30

30

30

30


  1. Rolling Method

This technique involves creating a pre-mix, adding an active ingredient, and then forming a film. The solvent is primarily water or a water-alcohol mixture. The metering roller determined thickness of film. The film is cured on the rollers before being cut into the desired shapes and sizes[2].

       
            Rolling Method.png
       

Figure No. 4 :– Rolling Method ( H Devaraj et. al 2018)

ODF’s By Using Rolling Method By An Some API

1.Diphenhydramine HCL 5,7

Preparation of film

The preparation of the polymeric solutions involved dissolving employing a magnetic stirrer to mix the polymer in the solvent until a clear solution was achieved. The plasticizer (20% w/w of dry weight of polymer) was added to the resulting clear polymeric solution and swirled. The drug (20% w/v) was added to the resulting clear solution and dissolved while being constantly stirred to produce a transparent drug solution in a polymeric solution. Based on the drugs penetration an appropriate permeation enhancer was chosen and applied. roughly twelve distinct formulation where created utilizing four distinct polymer and three levels of polymer concentration variation[21].


Table No . 8:-  Formilation Of Diphenhydramine Hcl Orally Fast -Dissolving Film In Mg [21]

 

11

 

F1

F2

F3

F4

F5

F6

F7

F8

F9

F10

F11

F12

Diphenhydramine HCL

25

25

25

25

25

25

25

25

25

25

25

25

CMC

166.67

83.20

124.95

 

104.16

 

 

 

124.95

 

 

104.16

Acacia

 

 

124.95

 

104.16

166.67

83.20

 

124.95

104.16

 

 

PEG400

83.20

166.67

 

124.95

 

143.83

 

 

 

124.95

 

143.83

Glycerol

 

 

124.95

 

145.83

 

83.20

166.67

124.95

 

145.83

 

Saccharin

4.17

4.17

4.17

4.17

4.17

4.17

4.17

4.17

4.17

4.17

4.17

4.17

Citric Acid

25.05

25.05

25.05

 

25.05

 

 

 

 

25.05

 

25.05

Mallic Acid

 

 

 

25.05

 

25.05

25.05

25.05

25.05

 

25.05

 

SLS

74.97

74.97

74.97

74.97

74.97

74.97

74.97

74.97

74.97

74.97

74.97

74.97


Comparative study of various drugs and its methods   :-


Table No:- 09 [9,14,18,10,1,12]

 

Sr. No.

Drug

Method

Material

Challenges

Evaluation

1.

Captopril

Solvent Casting Method

Api- Captopril

Excipient- film forming polymer, Plasticizer, solubilizer, sweetners, Flavouring agent

Moisture Control, Uniformity,

Hplc,

Dissolution, Sterility

2.

Zolpidem tartarate

Hot melt extrusion

Api- Zolpidem tartarate, Excipient – Plasticizer, sweeteners

Stability studies, clinical trial for safety and efficacy

Hplc, Dissolution test, Uniformity at dosage unit

3.

Telmisartan

Solid dispersion method (kneading method)

Api- Telmisartan Excipient- Plasticizer, Solubilizer, sweetners, flavouring agent.

Odf composition- Telmisartan, HPMC, Glycerin

Bioequivalence, Moisture Control

HPLC, Heavymetal

4.

Aprepitant

Solvent casting method

Api- Aprepitant, Film forming polymer

Taste masking, Stability, Moisture control

Assay HPLC, Residual solvent GC, Disintegration time

5.

Zolmitriptan

Solvent casting method

Api- Zolmitriptan.

HPMC,PVA, PVP

Excipient- solvent, favouring agent, colourant

Taste masking, stability, Flavour, Color uniformity

Hplc, In vitro dissolution

6.

Donepezil

Solvent casting method

Api - Donepezil

Formulation stability, Taste masking, Manufacturing stability

Thickness, Moisture control, Stability

7.

Ramosetron hcl.

Solvent casting method

Api- Ramosetron hcl

Film forming polymer, Hpmc

Pdf composition- Glycerin, Polysorbate, HPMC

Taste masking, Disintegration time, Stability

Thickness, Moisture, Stability

 

8.

Ondansetron

Hot melt extrusion

Api- ondansetron.

Plasticizer, sweetners

Odf composition- HPMC, Glycerin, Polysorbate

Uniform drug distribution, Film thickness and strength, Moisture sensitivity, Stability and shelf life.

HPLC, Heavy metal, Uniformity dosage unit.

9.

Benzocaine Menthol

Solvent Evaporation

HPMC, PVA

Stability, Volatility,  Taste masking

Thickness, Disintegration testing, Uniformity

10.

Olanzapine

Hot melt extrusion

Api- Olanzapine.HPMC, Favouring agemnt.

Odf composition- Olanazapine, HPMC, Glycerin, Polysorbate

Stability, Taste masking, Disintegration time, Bioavailability

Physical appearance, Drug uniformity, In-vitro release study

11.

Simethicone ODF

Hot melt extrusion

Film-forming polymers (HPMC,PVA,PVP) Plasticizer(Glycerin, glycol), Solvents(water, ethanol), Flavoring agents(mint,orange).

Stability of Simethicone, Film integrity, Taste masking

Disintegration time, Thickness uniformity, Moisture content


Challenges In Formulating ODF

There is tremendous sum of writing accessible now days on detailing, improvement and assessment of verbal dissolving movies. The challenges that related to noncompliance towards pharmaceutical require to be given need to hand[6].

1.Taste Masking of Bitter Drugs  

In the generation of quick-dissolving verbal movies, it is essential to cover the taste of severe drugs in arrange to increment persistent compliance, particularly among the elderly populace [6].

 2. Long duration of drying

The drying time is a significant calculate in the detailing of verbal movies, as it influences the rate of generation in mechanical settings. In common, a hot discuss broiler cannot be utilized to dry verbal movies that contain thermo-labile drugs; hence, they are  dried at room temperature instep, which would take indeed longer time to adequately dry [6].

3. Stability Against Temperature and humidity during handling and  Storage

Obtaining film soundness against stickiness is  challenging as film tend to retain water from muggy discuss and get melted. By the by, if the polymer utilized is exceedingly hygroscopic, it can frame hydrogen bond with water particles. In the nearness of stickiness, if the drug-polymer bond is weaker than polymer-water bond, undefined medicate nay experience stage division and crystallize[6].

4. Dose Uniformity

Insoluble materials debase undefined medicate to shape gems, consequently decreases disintegration rate of films. A few known strategies to guarantee dosage consistency incorporate :

1. Maintain a strategic distance from defining arrangement with tall consistency. For case, joining of polymers that frame exceedingly gooey arrangement may cause uneven conveyance and materials may knot together at one portion of the holder.

2. Utilize holders with level surface. Unpleasant surface decreases medicate and thickness

consistency, as arrangement may stay more on one side of the holder.

3. Utilize drying temperature that are underneath of dissolving point of drugs and excipients. Tall temperature amid drying may corrupt the chemicals in the movies.

4. Conduct test investigation based on determinations decided in pharmacopeia to assess the API substance in person film. For the most part, constrain of substance consistency should be between 85 to 115%.

 Evaluation of Oral Disintegrating Films

Organoleptic properties

For this, practice 

Thickness test- d, directed human taste boards are utilized. This in vivo taste evaluation is performed on human members. Utilizing taste sensors for screening, in-vitro taste assessment of ODFs is carried out. High-throughput taste detecting of such dosage details can be fulfilled utilizing in vitro innovation and methods. Examination of the sweetness level and taste-masking properties of substances is done utilizing both in vivo and in vitro methods[2].

 Mechanical properties-

Dryness test- The reason of this test is to decide a film’s capacity to adhere to a piece of paper pushed between strips. Tack portrays the will fulness with which a piece of paper or any other adornment is constrained in between two movies. Various stages are recognized, such as dust-free, set-to-touch, tack-free, dry-hard, dry-to-touch, dry through (dry-to-handle), dry to-recoat, and dry print- free. Various apparatuses are available for conducting this test [13].

Tensile Strength

Tensile quality shows mechanical quality of the verbal movies. It shows greatest stretch required to break the strip when connected at a point. It was decided utilizing Surface Analyzer Steady Miniaturized scale framework. It can be decided by isolating the connected stack at burst by the strip’s cross-sectional region, as appeared in the condition below.[6]

Tensile quality = (stack at disappointment / strip thickness ×strip width) ×10.6

Thickness test- Thickness test is conducted by measuring film at few diverse areas for occurrence 1 central point and 4 corners measured utilizing a calibrated advanced vernier caliper.. It is vital to affirm thickness consistency since it straightforwardly relates with the film’s dose accuracy.[2]

•Percent elongation- 

When a film is pushed, the example extends, which is alluded to as strain. The definition of strain is the alter in film length separated by the film specimen’s introductory length. The rate of stretching is quantitatively relative to the plasticizer substance of the film detailing. In common, expanded plasticizer substance in the film advances strip stretching. It can be decided by equation given below. [2]

Percentage elongation = (alter in length / introductory length) ×100. [2]

Packaging of oral disintegration film

Packing considerations are basic for capacity, assurance and soundness of measurement  shape. Bundling for verbal lean films incorporates thwart paper or plastic pockets, single pocket, aluminium pocket, rankle bundling with numerous units and Obstruction films are most commonly utilized for those drugs which are greatly dampness delicate.[19]  A assortment of choices in bundling are accessible for quick crumbling verbal films. Single bundling is mandatory for films which are pharmaceutical items; an aluminium pocket is the most commonly utilized bundling framework. APR- Labtech has created the fast card, a exclusive and protected imaginative bundling framework which is particularly outlined for quick films. The fast card is precisely the same estimate as a credit card and holds three quick films on each side. Each dosage can be taken out independently, permitting the quiet to carry six single, bundled dosages of his medicine in his satchel or wallet and have it promptly accessible [20].

CONCLUSION 

The main aim of the present study was to develop oral fast disintegrating film. Industries are considering the manufacture of commercially available products based on the increasing popularity of Odf formulations. The convenience and patient-friendly attributes of this dosage form make it a strong contender for widespread use in the market in the future[6]. The future of oral disintegrating films is characterized by advancements in formulation technology, expanding applications, and the incorporation of new technologies. Traditional dose forms are surpassed by these in terms of acceptability, patient compliance, and safety, with no risk of choking and greater efficacy. The fundamental purpose of ODF’s is to help paediatric, geriatric, and psychiatric patients who have trouble swallowing conventional dose forms. ODFs are now widely accessible for hypertension, acidity, allergy,  and pain, indicating their significance [2].

REFERENCES

  1. Kanna,S.,Nadendla,R.R., Satyanarayana, J., Karthikeya, V., Sonu, M.V., &Bhargavi, P.N.(2023). Formulation and Evaluation of Fast-Dissolving Oral Film of Rivaroxaben. Journal of Young Pharmacists,15(4), 687-695.
  2. Saie, D., Amit, G., Manisha, K., & Vilasrao, .2023 April (4):2320-2882 K. Orally Disintegrating Films-A Recent Modification In The Pharmaceutical Drug Delivery System .2023 April (4):2320-2882.
  3. Waghmare,P., Vrunal, M., & Mithun, M.(2023). Formulation and evaluation of fast dissolving oral film containing extracts of ocimum sanctum and glycyrrhiza glabra to treat mouth ulcer. Eur. Chem.Bull,12,2121-2129.
  4. Mahajan, Priya & Kaur, Amanpreet & Aggarwal, Geeta & SI, Harikumar. (2013). Mucoadhesive Drug Delivery System: A Review. International Journal of Drug Development and Research. 11-20. 10.20959/wjpps20174-8863.
  5. Wafa, A.,Raihan, R., Zhakfar, A. M., & Sudhakar, C. K. (2024).Oral Disintegrating Films: A Review.Journal of Natural Science Review,2(2), 60-74.
  6. Liew, Kai Bin & Gobal, Ganesan & Rofiq, Hanifah & Phang, Hiu & Lee, Siew-Keah & Ming, L   C & Helal Uddin, A. B. M. & Chew, Yik-Ling & Lakshminarayanan, Vijayakumar. (2023). Orally Disintegrating Film: A Review of Its Formulation and Manufacturing Method. Malaysian Journal of Medicine and Health Sciences. 19. 297-303. 10.47836/mjmhs.19.6.39.
  7. Bayraktar, O., Köse,M. D., & Ungun, N. (2022). Eggshell Membrane Based Turmeric Extract Loaded Orally Disintegrating Films. Current Drug Delivery, 19(5), 547–559.
  8. Ghodake, P. P., Karande, K. M., Osmani, R. A., Bhosale, R. R., Harkare, B. R., & Kale, B. B. (2013). Mouth Dissolving Films: Innovative Vehicle for Oral Drug Delivery. 2(10).
  9. Colucci, Larissa & Rodrigues, Leticia. (2022). Development of Orally Disintegrating Films HPMC Based Containing Captopril: Mechanical, Optical and Physicochemical Studies. Brazilian Archives of Biology and Technology. 65. 10.1590/1678-4324-2022220073.
  10. Rajni Bala, Shailesh Sharma, Formulation optimization and evaluation of fast dissolving film of aprepitant by using design of experiment, Bulletin of Faculty of Pharmacy, Cairo University, 56,(2),2018:159-168,1110-0931
  11. N, Surya & Marabathuni, V & Narapusetty, Naidu. (2022). Formation development and evolution of oral fast disintegrating film of zolmitriptan. International Journal of Indigenous Herbs and Drugs. 01-07. 10.46956/ijihd.v7i1.262.
  12. Patel, Zankahana And Bhura, Rahil and Shah, Samir. (2020). Formulation Optimization and Evaluation of Mouth Dissolving Film of Ramosetron Hydrochloride. International Journal of Current Pharmaceutical Research. 99-106. 10.22159/ijcpr.2020v12i3.38315.
  13. Muhammed, R. A., Yalman, Z., Noaman, B., Visht, S., Jabbar, S., & Salih, S. (2023). Innovations In Formulation And Evaluation Of Oral Fast Dissolving Film. Eurasian Journal of Science and Engineering, 9(2).
  14. Rani, T.. (2017). Formulation Development and Optimization of Oral Thin Films of Zolpidem Tartarate. Medical Science & Healthcare Practice. 1. 26. 10.22158/mshp.v1n1p26
  15. Dudekula Chand Basha, Bono Naga Sudha Box Behnken's Design of Fast-Dissolving Ondansetron Buccal Films and Assessing the Impact of Independent Variables on their Swelling and Folding Endurance Constraints. Indian Journal of Pharmaceutical Education and Research, 2024; 58(2s):s412s419. 
  16. Guo, S., Jiang, W., Shen, L., Zhang, G., Gao, Y., Yang, Y., & Yu, D. G. (2022). Electrospun Hybrid Films for Fast and Convenient Delivery of Active Herb Extracts. Membranes, 12(4), 398. 
  17. Singh, A., Kharb, V., & Saharan, V. A. (2020). Fast Dissolving/Disintegrating Dosage Forms of Natural Active Compounds and Alternative Medicines. Recent Patents on Drug Delivery & Formulation, 14(1), 21–39. 
  18. Muzammil Husain, Vinit V. Agnihotri, Sameer N. Goyal, Yogeeta O. Agrawal. Development, optimization and characterization of hydrocolloid based mouth dissolving film of Telmisartan for the treatment of hypertension, Food Hydrocolloids for Health, 2,2022:100064,26670259
  19. Ashwini Oral fast dissolving drug delivery: a modern approach for patient compliance Int. . Drug Regulatory Affairs, 2 (2) (2014),pp.49-60
  20. Vollmer, Ulrike, Galfetti and Paolo (2006). Rapid film: Oral: Thin Film (OTF) as anInnovative Drug Delivery System and Dosage Form. Drug Delivery Report. Spring summer 2006.
  21. Alejandro, Samantha F., Antonio, Aldrin L., Buena, Princess Angeline L., Buiza,Aimeriel   M., Perez, Arielle Grace A., Tubon, Nelson T, Valencia, Ara Mae B., Villespin, Vanessa Jae P. Formulation of an orally fast-dissolving film using diphenhydramine hydrochloride as the model drug by solvent casting method World Journal of Pharmaceutical Research 2016,5(3) 268-308.
  22. American Pharmacists Association. (2012). Handbook of Pharmaceutical Excipients (7th ed.). R. C. Rowe, P. J. Sheskey, W. G. Cook, & M. E. Fenton (Eds.). London: Pharmaceutical Press.
  23. Amin, A, Mishra, R. Manufacturing Techniques of Orally Dissolving Films. Pharmaceutical Technology, 2011; 35(1).
  24. Bhyan, B., Jangra, S., Kaur, M., & Singh, H. Orally Fast Dissolving Films: Innovations in Formulation and Technology. International Journal of Pharmaceutical Sciences Review and Research, 2011;9(2).
  25. Corniello C. Quick dissolving strips: from concept to commercialization. Drug Development Technology, 2006; 6: 68-71.
  26. Bhura, N; Sanghvi, K; Patel, U; Parmar, V and Patel, D. A review on fast    dissolving film. International Journal of Pharmaceutical Sciences Review and Research, 2012; 1(3): 66-89.
  27. Dixit, R.P. and Puthli S.P. Oral strip technology: Overview and future potential. Journal of Controlled Release, 2009; 139: 94–97.
  28. Gohel MC and Sharma R. Development of taste masked film of valdecoxib for oral use. Indian Journal of Pharmaceutical Sciences, 2010; 320-323.
  29. Keshavarao, K.P., et.al. Formulation and Evaluation of Mouth Dissolving Film Containing Rofecoxib. International Research Journal of Pharmacy, 2011; 2(3).
  30. Kulkarni, A.S., Deokule, H.A., Mane, M.S. and Ghadge, D.M. Exploration of Different Polymers for Use in the Formulation of Oral Fast Dissolving Strips. Journal of Current Pharmaceutical Research, 2010; 2(1): 33-35.
  31. Shargel, L. 2004. Applied Biopharmaceutics & Pharmacokinetics (5th ed.).New York: The McGraw-Hill Companies.
  32. Siemann, U. Solvent cast technology: a versatile tool for thin film production. Prog. Colloid Polym. Sci., 2005; 130: 1–14.
  33. Sweetman, S. Martindale: The Complete Drug Reference. British Journal of Clinical Pharmacology, 2009; 49(6): 440
  34. Wale A. and Weller P.J. (2011). Handbook of Pharmaceutical Excipients 7th ed. 24, 27, 352, 448.
  35. Watson, D. G. 1999. Pharmaceutical analysis: A textbook for pharmacy students  and pharmaceutical chemists. Edinburgh [Scotland]: Churchill Livingstone.
  36. Thakur S. Mouth Dissolving Films: A Review. Int J Pharm Bio Sci., 2013; 4(1): 899- 908.
  37. Suresh B, Halloran D, James L. Quick dissolving films: A novel approach to drug delivery. Drug del tech.
  38. Aulton, M. Taylor, K. Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd Edition. Churchill Livingstone, 2007; 650: 661-662.
  39. Delivery System and Dosage Form. International Journal of Chem Tech Research, 2(1), 576-583.
  40. Chavan, V., Radhakisan, U. R., Tribhuvan, N. Mouth Dissolving Film and their Patent: An Overview. Internation Research Journal of Pharmacy, 2012: 3(9).
  41. Gavaskar B, Kumar S, Guru S and Ray M. Overview on fast dissolving films. International  Journal  of  Pharmacy  and  Pharmaceutical Sciences, 2009; 3(2): 29-33.
  42. Ghodake, P., Karande, K., Osmani, R., Bhosale, R., Harkare, B., & Kale, B. International Journal of Pharma Research & Review. Mouth Dissolving Films: Innovative Vehicle for Oral Drug Delivery, 2013; 2(10): 41-47.
  43. Hassan, S. Method Development of Diphenhydramine HCl (C17H21NO.HCl) on Spectrophotometer. Hamdard Institute of Education and Social Sciences. Pakistan, 2015; 8(3). Israel K. and Leo M. Salivary stimulant, U.S. Patent. 4820506
  44. Kalyan S, Bansal M. Recent Trend in the Development of Oral dissolving Film. Int J Pharmaceut Res, 2012; 4(2): 725-733.
  45. Xiao, L., Yi, T., & Liu, Y. A new self-microemulsifying mouth dissolving to improve the oral bioavailability of poorly water soluble drugs. Drug Development and Industrial Pharmacy, 2013; 1284-1290.
  46. Trissel, A. Trissel's Stability of Compounded Formulations, 5th Edition.American Pharmacist's Association, 2012; 475-476.
  47. Suhas, S., Dattaprasad, N., Ganesh, A., Prashant, B., Prajakta, S. Fast Dissolving Oral films: Easy way of Oral delivery. International Journal of Current Trends in Pharmaceutical Research, 2014; 2(3).
  48. Siddiqui, N., Garg, G., & Sharma, P. kumar. A Short Review on "A Novel Approach in Oral Fast Dissolving Drug Delivery System and their Patents. Advances in Biological Research, 2011; 5(6).
  49. Radhakishan UR, Chavan V, Tribhuvan N. Mouth dissolving films and their patents: An overview. Int. Res. J. Pharm., 2012; 3(9): 39-42.
  50. Reddy, n., reddy, a., srinivasan, s., kavitha, k., kumar, r., &singh, j. International journal of inventions in pharmaceutical sciences. Review on: better solubility enhancement of poorly water soluble  drugs, 2013; 1(4): 267-273.
  51. Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T and Itoh Y. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. International Journal of Pharmaceutical Sciences, 2009; 98–102

Reference

  1. Kanna,S.,Nadendla,R.R., Satyanarayana, J., Karthikeya, V., Sonu, M.V., &Bhargavi, P.N.(2023). Formulation and Evaluation of Fast-Dissolving Oral Film of Rivaroxaben. Journal of Young Pharmacists,15(4), 687-695.
  2. Saie, D., Amit, G., Manisha, K., & Vilasrao, .2023 April (4):2320-2882 K. Orally Disintegrating Films-A Recent Modification In The Pharmaceutical Drug Delivery System .2023 April (4):2320-2882.
  3. Waghmare,P., Vrunal, M., & Mithun, M.(2023). Formulation and evaluation of fast dissolving oral film containing extracts of ocimum sanctum and glycyrrhiza glabra to treat mouth ulcer. Eur. Chem.Bull,12,2121-2129.
  4. Mahajan, Priya & Kaur, Amanpreet & Aggarwal, Geeta & SI, Harikumar. (2013). Mucoadhesive Drug Delivery System: A Review. International Journal of Drug Development and Research. 11-20. 10.20959/wjpps20174-8863.
  5. Wafa, A.,Raihan, R., Zhakfar, A. M., & Sudhakar, C. K. (2024).Oral Disintegrating Films: A Review.Journal of Natural Science Review,2(2), 60-74.
  6. Liew, Kai Bin & Gobal, Ganesan & Rofiq, Hanifah & Phang, Hiu & Lee, Siew-Keah & Ming, L   C & Helal Uddin, A. B. M. & Chew, Yik-Ling & Lakshminarayanan, Vijayakumar. (2023). Orally Disintegrating Film: A Review of Its Formulation and Manufacturing Method. Malaysian Journal of Medicine and Health Sciences. 19. 297-303. 10.47836/mjmhs.19.6.39.
  7. Bayraktar, O., Köse,M. D., & Ungun, N. (2022). Eggshell Membrane Based Turmeric Extract Loaded Orally Disintegrating Films. Current Drug Delivery, 19(5), 547–559.
  8. Ghodake, P. P., Karande, K. M., Osmani, R. A., Bhosale, R. R., Harkare, B. R., & Kale, B. B. (2013). Mouth Dissolving Films: Innovative Vehicle for Oral Drug Delivery. 2(10).
  9. Colucci, Larissa & Rodrigues, Leticia. (2022). Development of Orally Disintegrating Films HPMC Based Containing Captopril: Mechanical, Optical and Physicochemical Studies. Brazilian Archives of Biology and Technology. 65. 10.1590/1678-4324-2022220073.
  10. Rajni Bala, Shailesh Sharma, Formulation optimization and evaluation of fast dissolving film of aprepitant by using design of experiment, Bulletin of Faculty of Pharmacy, Cairo University, 56,(2),2018:159-168,1110-0931
  11. N, Surya & Marabathuni, V & Narapusetty, Naidu. (2022). Formation development and evolution of oral fast disintegrating film of zolmitriptan. International Journal of Indigenous Herbs and Drugs. 01-07. 10.46956/ijihd.v7i1.262.
  12. Patel, Zankahana And Bhura, Rahil and Shah, Samir. (2020). Formulation Optimization and Evaluation of Mouth Dissolving Film of Ramosetron Hydrochloride. International Journal of Current Pharmaceutical Research. 99-106. 10.22159/ijcpr.2020v12i3.38315.
  13. Muhammed, R. A., Yalman, Z., Noaman, B., Visht, S., Jabbar, S., & Salih, S. (2023). Innovations In Formulation And Evaluation Of Oral Fast Dissolving Film. Eurasian Journal of Science and Engineering, 9(2).
  14. Rani, T.. (2017). Formulation Development and Optimization of Oral Thin Films of Zolpidem Tartarate. Medical Science & Healthcare Practice. 1. 26. 10.22158/mshp.v1n1p26
  15. Dudekula Chand Basha, Bono Naga Sudha Box Behnken's Design of Fast-Dissolving Ondansetron Buccal Films and Assessing the Impact of Independent Variables on their Swelling and Folding Endurance Constraints. Indian Journal of Pharmaceutical Education and Research, 2024; 58(2s):s412s419. 
  16. Guo, S., Jiang, W., Shen, L., Zhang, G., Gao, Y., Yang, Y., & Yu, D. G. (2022). Electrospun Hybrid Films for Fast and Convenient Delivery of Active Herb Extracts. Membranes, 12(4), 398. 
  17. Singh, A., Kharb, V., & Saharan, V. A. (2020). Fast Dissolving/Disintegrating Dosage Forms of Natural Active Compounds and Alternative Medicines. Recent Patents on Drug Delivery & Formulation, 14(1), 21–39. 
  18. Muzammil Husain, Vinit V. Agnihotri, Sameer N. Goyal, Yogeeta O. Agrawal. Development, optimization and characterization of hydrocolloid based mouth dissolving film of Telmisartan for the treatment of hypertension, Food Hydrocolloids for Health, 2,2022:100064,26670259
  19. Ashwini Oral fast dissolving drug delivery: a modern approach for patient compliance Int. . Drug Regulatory Affairs, 2 (2) (2014),pp.49-60
  20. Vollmer, Ulrike, Galfetti and Paolo (2006). Rapid film: Oral: Thin Film (OTF) as anInnovative Drug Delivery System and Dosage Form. Drug Delivery Report. Spring summer 2006.
  21. Alejandro, Samantha F., Antonio, Aldrin L., Buena, Princess Angeline L., Buiza,Aimeriel   M., Perez, Arielle Grace A., Tubon, Nelson T, Valencia, Ara Mae B., Villespin, Vanessa Jae P. Formulation of an orally fast-dissolving film using diphenhydramine hydrochloride as the model drug by solvent casting method World Journal of Pharmaceutical Research 2016,5(3) 268-308.
  22. American Pharmacists Association. (2012). Handbook of Pharmaceutical Excipients (7th ed.). R. C. Rowe, P. J. Sheskey, W. G. Cook, & M. E. Fenton (Eds.). London: Pharmaceutical Press.
  23. Amin, A, Mishra, R. Manufacturing Techniques of Orally Dissolving Films. Pharmaceutical Technology, 2011; 35(1).
  24. Bhyan, B., Jangra, S., Kaur, M., & Singh, H. Orally Fast Dissolving Films: Innovations in Formulation and Technology. International Journal of Pharmaceutical Sciences Review and Research, 2011;9(2).
  25. Corniello C. Quick dissolving strips: from concept to commercialization. Drug Development Technology, 2006; 6: 68-71.
  26. Bhura, N; Sanghvi, K; Patel, U; Parmar, V and Patel, D. A review on fast    dissolving film. International Journal of Pharmaceutical Sciences Review and Research, 2012; 1(3): 66-89.
  27. Dixit, R.P. and Puthli S.P. Oral strip technology: Overview and future potential. Journal of Controlled Release, 2009; 139: 94–97.
  28. Gohel MC and Sharma R. Development of taste masked film of valdecoxib for oral use. Indian Journal of Pharmaceutical Sciences, 2010; 320-323.
  29. Keshavarao, K.P., et.al. Formulation and Evaluation of Mouth Dissolving Film Containing Rofecoxib. International Research Journal of Pharmacy, 2011; 2(3).
  30. Kulkarni, A.S., Deokule, H.A., Mane, M.S. and Ghadge, D.M. Exploration of Different Polymers for Use in the Formulation of Oral Fast Dissolving Strips. Journal of Current Pharmaceutical Research, 2010; 2(1): 33-35.
  31. Shargel, L. 2004. Applied Biopharmaceutics & Pharmacokinetics (5th ed.).New York: The McGraw-Hill Companies.
  32. Siemann, U. Solvent cast technology: a versatile tool for thin film production. Prog. Colloid Polym. Sci., 2005; 130: 1–14.
  33. Sweetman, S. Martindale: The Complete Drug Reference. British Journal of Clinical Pharmacology, 2009; 49(6): 440
  34. Wale A. and Weller P.J. (2011). Handbook of Pharmaceutical Excipients 7th ed. 24, 27, 352, 448.
  35. Watson, D. G. 1999. Pharmaceutical analysis: A textbook for pharmacy students  and pharmaceutical chemists. Edinburgh [Scotland]: Churchill Livingstone.
  36. Thakur S. Mouth Dissolving Films: A Review. Int J Pharm Bio Sci., 2013; 4(1): 899- 908.
  37. Suresh B, Halloran D, James L. Quick dissolving films: A novel approach to drug delivery. Drug del tech.
  38. Aulton, M. Taylor, K. Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd Edition. Churchill Livingstone, 2007; 650: 661-662.
  39. Delivery System and Dosage Form. International Journal of Chem Tech Research, 2(1), 576-583.
  40. Chavan, V., Radhakisan, U. R., Tribhuvan, N. Mouth Dissolving Film and their Patent: An Overview. Internation Research Journal of Pharmacy, 2012: 3(9).
  41. Gavaskar B, Kumar S, Guru S and Ray M. Overview on fast dissolving films. International  Journal  of  Pharmacy  and  Pharmaceutical Sciences, 2009; 3(2): 29-33.
  42. Ghodake, P., Karande, K., Osmani, R., Bhosale, R., Harkare, B., & Kale, B. International Journal of Pharma Research & Review. Mouth Dissolving Films: Innovative Vehicle for Oral Drug Delivery, 2013; 2(10): 41-47.
  43. Hassan, S. Method Development of Diphenhydramine HCl (C17H21NO.HCl) on Spectrophotometer. Hamdard Institute of Education and Social Sciences. Pakistan, 2015; 8(3). Israel K. and Leo M. Salivary stimulant, U.S. Patent. 4820506
  44. Kalyan S, Bansal M. Recent Trend in the Development of Oral dissolving Film. Int J Pharmaceut Res, 2012; 4(2): 725-733.
  45. Xiao, L., Yi, T., & Liu, Y. A new self-microemulsifying mouth dissolving to improve the oral bioavailability of poorly water soluble drugs. Drug Development and Industrial Pharmacy, 2013; 1284-1290.
  46. Trissel, A. Trissel's Stability of Compounded Formulations, 5th Edition.American Pharmacist's Association, 2012; 475-476.
  47. Suhas, S., Dattaprasad, N., Ganesh, A., Prashant, B., Prajakta, S. Fast Dissolving Oral films: Easy way of Oral delivery. International Journal of Current Trends in Pharmaceutical Research, 2014; 2(3).
  48. Siddiqui, N., Garg, G., & Sharma, P. kumar. A Short Review on "A Novel Approach in Oral Fast Dissolving Drug Delivery System and their Patents. Advances in Biological Research, 2011; 5(6).
  49. Radhakishan UR, Chavan V, Tribhuvan N. Mouth dissolving films and their patents: An overview. Int. Res. J. Pharm., 2012; 3(9): 39-42.
  50. Reddy, n., reddy, a., srinivasan, s., kavitha, k., kumar, r., &singh, j. International journal of inventions in pharmaceutical sciences. Review on: better solubility enhancement of poorly water soluble  drugs, 2013; 1(4): 267-273.
  51. Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T and Itoh Y. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. International Journal of Pharmaceutical Sciences, 2009; 98–102

Photo
Gopal Khillari
Corresponding author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute of Pharmacy, Maregaon

Photo
Anushka Ghubde
Co-author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute of Pharmacy, Maregaon

Photo
Ashutosh Khadatkar
Co-author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute of Pharmacy, Maregaon

Photo
Dr. Nilesh Chachda
Co-author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute of Pharmacy, Maregaon

Gopal Khillari*, Anushka Ghubde, Ashutosh Khadatkar, Dr. Nilesh Chachda, Oral Disintegrating Film: Comparative Review of Formulation Strategies and Production Challenges, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 12, 1810-1824. https://doi.org/10.5281/zenodo.14444216

More related articles
Post Traumatic Stress Disorder and Associated Psyc...
Abhirami Jayaram, K. Vineetha, A. R. Shabaraya, ...
A Comprehensive Review on Analytical Methods for T...
Krutanjali Nikumbh, Kiran Dhamak, ...
Formulation And Evaluation of Herbal Body Wash Sol...
Tanuja Kadam , Bahaisti Patel, Sakshi Labhade , Rutuja Shirode ,...
Recent Biomarker in Alzheimer’s Disease: A Systemic Review...
Sabitri Pradhan , Rintu Saikia , Pranita Sunar, ...
Quality Control And Quality Assurance In Pharmaceuticals...
Sayali Dilip Patil, Mayuri Kaduba Raut, Nikhil Prakash Rathod, ...
Related Articles
Formulation, Development And Evaluation Of Polyherbal Wound Healing Gel ...
Omkar Salunkhe, Pranjal Chougule , Nilesh Chougule , ...
Emulgel and Nano Emulgel as Topical Drug Delivery System ...
Narendra Umale, S. Wankhade, Minakshi Hingane, Samiksha Kathane, Shravani Kadu, Dr. H. S. Sawarkar, ...
More related articles
Formulation And Evaluation of Herbal Body Wash Solution ...
Tanuja Kadam , Bahaisti Patel, Sakshi Labhade , Rutuja Shirode , Shubham Bodkhe , Roshni Sayyad, Ka...
Formulation And Evaluation of Herbal Body Wash Solution ...
Tanuja Kadam , Bahaisti Patel, Sakshi Labhade , Rutuja Shirode , Shubham Bodkhe , Roshni Sayyad, Ka...